Quantcast
Home > Quotes > AMPE

Ampio Pharmaceuticals, Inc. (AMPE) Quote & Summary Data

AMPE 
$0.5581
*  
0.0255
4.79%
Get AMPE Alerts
*Delayed - data as of Dec. 11, 2018 13:31 ET  -  Find a broker to begin trading AMPE now
Exchange:AMEX
Industry: Health Care
Community Rating:
View:    AMPE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
Today's High / Low
$ 0.5663 / $ 0.533
Share Volume
2,953,610
90 Day Avg. Daily Volume
2,281,018
Previous Close
$ 0.5326
52 Week High / Low
$ 4.9499 / $ 0.3511
Market Cap
59,558,488
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.62

Intraday Chart

Shares Traded

Share Volume:
2,953,610
90 Day Avg. Daily Volume:
2,281,018

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.39

Trading Range

The current last sale of $0.5581 is 58.96% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.5663 $ 4.9499
 Low: $ 0.533 $ 0.3511

Company Description (as filed with the SEC)

We are a biopharmaceutical company focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. Our product portfolio is primarily based on the work of Dr. David Bar-Or, the Director of Trauma Research LLC for the Swedish Medical Center located in Englewood, CO, St. Anthony Hospital located in Lakewood, CO and the Medical Center of Plano, Plano Texas. For over two decades, while directing these trauma research laboratories, Dr. Bar-Or and his staff have built a robust portfolio of product candidates focusing on inflammatory conditions. Our initial clinical programs were selected from Dr. Bar-Or's research based on certain criteria, particularly the ability to advance the candidates rapidly into late-stage clinical trials.  ... More ...  

Research Brokers before you trade

Want to trade FX?

Analyst Info